Progyny Raises 2026 Revenue Guidance Following Record Q3 Results
Progyny (PGNY) reported record revenue and profitability for the third quarter, driven by strong operational performance and significant cash flow generation. The company's growth is supported by a substantial expansion in its member base, adding approximately 1.3 million new covered lives. Following these results, management has raised its full-year 2026 revenue outlook to a range of $1.365 billion to $1.385 billion. This upward revision reflects the company's increasing scale and momentum within the fertility benefits sector.
Tickers: $PGNY
Topics: cash flow earnings profitability revenue growth